Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.494
Bid: 1.472
Ask: 1.506
Change: -0.006 (-0.40%)
Spread: 0.034 (2.31%)
Open: 1.53
High: 1.53
Low: 1.462
Prev. Close: 1.50
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 3Q21 Separate Condensed Financial Results

12 Nov 2021 07:00

RNS Number : 1601S
Commercial Intnl Bank (Egypt) SAE
12 November 2021
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/1601S_1-2021-11-11.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Balance Sheet as at September 30, 2021

 

 

Notes

Sep. 30, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash and balances at the central bank

7

33,207,606

 

33,572,597

 

Due from banks

8

71,953,894

 

86,997,034

 

Loans and advances to banks, net

10

-

 

776,980

 

Loans and advances to customers, net

11

139,110,172

 

118,854,880

 

Derivative financial instruments

 

266,997

 

248,759

 

Investments

 

 

 

 

 

- Financial Assets at Fair Value through P&L

12

206,699

 

359,959

 

- Financial Assets at Fair Value through OCI

12

211,854,018

 

147,646,432

 

- Amortized cost

12

20,299,222

 

25,020,917

 

- Investments in associates and subsidiaries

13

1,023,350

 

874,348

 

Other assets

 

10,515,647

 

9,095,212

 

Deferred tax assets (Liabilities)

 

449,617

 

437,772

 

Property and equipment

14

2,456,076

 

2,259,940

 

Total assets

 

491,343,298

 

426,144,830

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

15

1,542,750

 

8,815,561

 

Due to customers

16

403,085,553

 

340,086,524

 

Derivative financial instruments

 

324,863

 

331,073

 

Current tax liabilities

 

1,962,488

 

859,582

 

Other liabilities

 

7,945,461

 

5,679,266

 

Issued debt instruments

17

1,556,032

 

-

 

Other loans

 

5,633,101

 

7,746,946

 

Provisions

18

3,341,155

 

3,221,252

 

Total liabilities

 

425,391,403

 

366,740,204

 

Equity

 

 

 

 

 

Issued and paid up capital

 

19,702,418

 

14,776,813

 

Reserves

 

34,449,076

 

33,085,554

 

Reserve for employee stock ownership plan (ESOP)

 

1,542,292

 

1,064,648

 

Retained earnings *

 

10,258,109

 

10,477,611

 

Total equity and net profit for the period / year

 

65,951,895

 

59,404,626

 

Total liabilities and equity

 

491,343,298

 

426,144,830

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Review report attached)

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

 

 

 

Condensed Separate Interim Income Statement for the period ended September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

Last 3 Months

 

Last 9 Months

Last 3 Months

Last 9 Months

 

 

 

 

Sep. 30, 2021

 

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2020

 

 

 

 

EGP Thousands

 

EGP Thousands

EGP Thousands

EGP Thousands

 

Interest and similar income

 

 

11,593,432

 

32,568,923

10,576,974

31,499,616

 

Interest and similar expense

 

 

(5,160,860)

 

(14,463,322)

(4,220,982)

(12,666,727)

 

Net interest income

 

 

6,432,572

 

18,105,601

6,355,992

18,832,889

 

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

1,096,988

 

2,895,435

660,822

2,140,039

 

Fee and commission expense

 

 

(442,737)

 

(1,129,866)

(310,289)

(803,346)

 

 

Net fee and commission income

 

 

654,251

 

1,765,569

350,533

1,336,693

 

 

 

 

 

 

 

 

 

 

Dividend income

 

 

18,854

 

82,426

62,431

88,393

 

Net trading income

5

 

210,117

 

484,774

49,736

226,967

 

Profits (Losses) on financial investments

12

 

56,589

 

634,108

53,913

885,918

 

Administrative expenses

 

 

(1,463,520)

 

(4,382,463)

(1,339,447)

(4,184,345)

 

Other operating (expenses) income

 

 

(252,886)

 

(1,366,178)

(186,143)

(2,033,630)

 

Impairment release (charges) for credit losses

 

 

(306,694)

 

(1,325,770)

(1,602,505)

(3,862,159)

 

Profit before income tax

 

 

5,349,283

 

13,998,067

3,744,510

11,290,726

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(1,524,957)

 

(4,115,227)

(1,306,332)

(3,958,540)

 

Deferred tax assets (Liabilities)

 

 

(6,983)

 

11,845

(44,220)

63,381

 

Net profit for the period

 

 

3,817,343

 

9,894,685

2,393,958

7,395,567

 

 

 

 

 

 

 

 

 

 

Earning per share

6

 

 

 

 

 

 

 

Basic

 

 

1.71

 

4.44

1.08

3.34

 

Diluted

 

 

1.70

 

4.42

1.07

3.32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

Sherif Samy

 

 

 

 

 

 

CEO & Managing Director

 

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

            

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Last 3 Months

 

Last 9 Months

Last 3 Months

Last 9 Months

 

 

 

 

 

 

Sep. 30, 2021

 

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2020

 

 

 

 

 

 

EGP Thousands

 

EGP Thousands

EGP Thousands

EGP Thousands

 

 

 

Net profit for the period

 

 

3,817,343

 

9,894,685

2,393,958

7,395,567

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income

 

 

(700,186)

 

(2,374,495)

(807,000)

(2,290,581)

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

(72,956)

 

(177,362)

(21,575)

(76,717)

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

(83,602)

 

(98,246)

(2,320)

88,192

 

 

 

Total comprehensive income for the period

 

 

2,960,599

 

7,244,582

1,563,063

5,116,461

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended September 30, 2021

 

 

 

 

 

Notes

Sep. 30, 2021

Sep. 30, 2020

 

 

 

EGP Thousands

EGP Thousands

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax

 

13,998,067

11,290,726

 

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

14

636,413

503,005

 

Impairment charge for credit losses (Loans and advances to customers and banks)

 

1,385,835

3,761,572

 

Other provisions charges

18

190,858

972,522

 

Impairment charge for credit losses (due from banks)

 

38,181

12,395

 

Impairment (Released) charge for credit losses (financial investments)

 

(98,246)

88,192

 

Impairment (Released) charge for other assets

 

31,975

56,245

 

Exchange revaluation differences for financial assets at fair value through OCI

 

40,050

238,906

 

Impairment (Released) charge financial assets at fair value through OCI

 

-

79,126

 

Utilization of other provisions

18

(44,978)

(1,479)

 

Other provisions no longer used

18

(12,255)

(6,022)

 

Exchange differences of other provisions

18

(13,722)

(17,670)

 

Losses (profits) from selling property, plant and equipment

 

(2,124)

(872)

 

Losses (profits) from selling financial investments

12

(643,467)

(979,144)

 

Shares based payments

 

477,644

447,694

 

Impairment (Released) charges of investments in associates and subsidiaries

 

9,359

14,100

 

Operating losses (profits) before changes in operating assets and liabilities

 

15,993,590

16,459,296

 

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

 

(272,238)

(5,824,055)

 

Financial assets at fair value through P&L

12

153,260

74,562

 

Derivative financial instruments

 

(24,448)

(4,144)

 

Loans and advances to banks and customers

10 - 11

(20,847,787)

(2,311,001)

 

Other assets

 

(1,631,518)

653,639

 

Due to banks

15

(7,272,811)

(2,999,346)

 

Due to customers

16

62,999,029

26,727,228

 

Income tax obligations paid

 

(2,152,739)

(4,389,254)

 

Other liabilities

 

1,414,946

(4,645,456)

 

Net cash used in (generated from) operating activities

 

48,359,284

23,741,469

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from investments in associates.

 

-

750

 

Proceeds (payments) for investment in associates.

 

(158,360)

(680,836)

 

Payment for purchases of property, plant, equipment and branches constructions

 

(669,801)

(809,475)

 

Proceeds from selling property, plant and equipment

 

2,124

872

 

Proceeds from redemption of financial assets at amortized cost

 

4,725,376

37,493,345

 

Payment for purchases of financial assets at amortized cost

 

(3,844)

-

 

Payment for purchases of financial assets at fair value through OCI

 

(207,918,546)

(55,656,650)

 

Proceeds from selling financial assets at fair value through OCI

 

146,303,855

24,096,252

 

Net cash generated from (used in) investing activities

 

(57,719,196)

4,444,258

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Received (Repaid) in long term loans

 

(2,113,845)

4,492,249

 

Dividend paid

 

(1,360,652)

(3,370,464)

 

Issued debt instruments

 

1,556,032

-

 

Capital increase

 

-

85,992

 

Net cash generated from (used in) financing activities

 

(1,918,465)

1,207,777

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

 

(11,278,377)

29,393,504

 

Beginning balance of cash and cash equivalent

 

75,965,247

22,895,017

 

Cash and cash equivalent at the end of the period

 

64,686,870

52,288,521

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

 

33,207,606

35,579,884

 

Due from banks

 

72,015,406

56,274,241

 

Treasury bills and other governmental notes

9

65,654,913

31,967,018

 

Obligatory reserve balance with CBE

 

(27,183,002)

(29,856,359)

 

Due from banks with maturities more than three months

 

(16,980,376)

(8,958,909)

 

Treasury bills with maturity more than three months

 

(62,027,677)

(32,717,354)

 

Total cash and cash equivalent

 

64,686,870

52,288,521

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2020

Sep. 30, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Capital increase

85,992

-

-

-

-

-

-

-

-

85,992

Transferred to reserves

-

590,106

7,840,287

-

1,440

-

-

(8,431,833)

-

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Net profit for the period

-

-

-

-

-

-

-

7,395,567

-

7,395,567

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(76,717)

-

76,717

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(2,290,581)

-

-

-

(2,290,581)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

88,192

-

-

-

88,192

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

447,694

447,694

Ending balance

 

14,776,813

2,778,135

24,314,716

1,549,445

14,906

1,832,675

6,423

7,472,283

1,410,846

54,156,242

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2021

Sep. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Capital increase

4,925,605

-

(4,925,605)

-

-

-

-

-

-

-

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit for the period

-

-

-

-

-

-

-

9,894,685

-

9,894,685

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(177,362)

-

177,362

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(2,374,495)

-

-

-

(2,374,495)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(98,246)

-

-

-

(98,246)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

477,644

477,644

Ending balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

1,320,884

9,141

10,258,109

1,542,292

65,951,895

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFFFVILTLLLIL
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.